Parkinson's Disease Clinical Trials in Chicago

Showing 81-84 of 84 trials

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

NCT00203034

Study for patients currently using Levodopa/Carbidopa who will be assigned to receive either Rasagiline or Placebo

Teva Branded Pharmaceutical Products R&D, Inc.472 participantsStarted May 2000

Chicago, Illinois, United States • New York, New York, United States • Rochester, New York, United States +1 more locations

COMPLETEDPHASE42.2 miles

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

NCT00043849

The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia complicated by coexistent parkinsonism, or patients with Parkinson's disease with dementia \[PDD\] who have episodes of agitation or psychosis. The secondary aim is to determine the safety and tolerability, particularly the influence on parkinsonism, of quetiapine when used to treat psychosis and/or agitation in patients with dementia complicated by coexistent parkinsonism.

DementiaParkinson Disease

National Institute on Aging (NIA)60 participantsStarted Jul 2002

Birmingham, Alabama, United States • La Jolla, California, United States • Long Beach, California, United States +18 more locations

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Parkinson's Disease Trials in Other Cities

Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease

SLV308 for Treatment of Patients With Early Parkinson's Disease

Other Conditions in Chicago